Diuretic-induced ventricular ectopic activity

The American Journal of Medicine
O B HollandL Kuhnert


The need to avoid hypokalemia during diuretic therapy in nondigitalized patients has been questioned. Twenty-one patients with (1) mild essential hypertension, (2) plasma potassium of less than 3.5 meq/liter during previous diuretic treatment, and (3) normal findings [less than 6 unifocal ventricular premature beats/hour] on 24-hour ambulatory electrocardiographic monitoring and exercise testing were treated with hydrochlorothiazide (50 mg twice a day) for four weeks and then ambulatory electrocardiographic monitoring and exercise testing were repeated. Ambulatory electrocardiographic monitoring revealed that ventricular ectopic activity developed in seven patients and complex ventricular ectopic activity (multifocal ventricular premature beats, ventricular couplets and/or ventricular tachycardia) in four. Only two of these seven had ventricular ectopic activity during exercise testing while they were hypokalemic. Potassium repletion in these seven patients with spironolactone abolished complex ventricular ectopic activity and reduced unifocal ventricular premature beats significantly (p less than 0.01) from an average of 71.2 ventricular premature beats/hour/patient during hydrochlorothiazide treatment to 5.4 ventricular prema...Continue Reading

Associated Clinical Trials


May 4, 1977·The American Journal of Cardiology·A CalvertR Gorlin
Sep 4, 1976·Lancet·J M ClarkeG R Venning
Feb 1, 1979·The American Journal of Cardiology·B Lown
May 1, 1978·Kidney International·E R Yendt, M Cohanim
May 22, 1978·The American Journal of Cardiology·D C HarrisonR A Winkle
Jan 2, 1978·JAMA : the Journal of the American Medical Association·M Duke
May 26, 1977·The American Journal of Cardiology·B Lown, T B Graboys
Mar 1, 1975·Chest·M G LopesJ S Schroeder
Mar 1, 1966·Progress in Cardiovascular Diseases·C FischK Greenspan
Sep 1, 1967·Archives of Internal Medicine·S Davidson, B Surawicz
Jul 1, 1953·The Journal of Clinical Investigation·G A PERERA
Jan 1, 1955·British Heart Journal·P M McALLEN
Apr 1, 1960·Circulation·W F WEAVER, H B BURCHELL
Dec 1, 1962·The Journal of Clinical Endocrinology and Metabolism·R HORTON, E G BIGLIERI

❮ Previous
Next ❯


Nov 1, 1994·Journal of Clinical Pharmacology·J A KruseM A Geheb
Nov 1, 1987·Journal of General Internal Medicine·C H Hennekens
Mar 1, 1993·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J E TetzlaffM T Walsh
Oct 1, 1987·American Heart Journal·M A Weber
May 1, 1989·American Heart Journal·S C ChakkoM Gheorghiade
Jun 1, 1983·The American Journal of Cardiology·N M Kaplan
Jul 31, 1986·The American Journal of Cardiology·P K Whelton, A J Watson
Sep 1, 1987·The American Journal of Cardiology·J D CohenK A Daniels
Jun 15, 1988·The American Journal of Cardiology·M R Weir, J R Sowers
Aug 1, 1982·The American Journal of Medicine·J T HarringtonJ P Kassirer
Oct 1, 1990·Journal of the American College of Cardiology·S S GottliebM Packer
Feb 1, 1984·Journal of the American College of Cardiology·E D Frohlich
Dec 1, 1986·Journal of the American College of Cardiology·M AjiokaT Ozawa
Jul 1, 1987·Journal of the American College of Cardiology·D M SalernoV Chepuri
Dec 9, 1982·The New England Journal of Medicine
Mar 21, 1985·The New England Journal of Medicine·J P Kassirer, J T Harrington
Sep 5, 1985·The New England Journal of Medicine·D Hyman, N M Kaplan
Jul 14, 2011·QJM : Monthly Journal of the Association of Physicians·E M Abdel-RahmanR A Balogun
Oct 1, 1990·Journal of Internal Medicine·J HallasN Damsbo
Jun 21, 2001·The Journal of Clinical Hypertension·M Moser
Jan 31, 2003·The Journal of Clinical Hypertension·Marvin Moser
Nov 1, 1990·Pacing and Clinical Electrophysiology : PACE·S S Gottlieb
Feb 1, 1984·British Heart Journal·J K McKibbinI W Obel
Mar 1, 1989·British Heart Journal·C Blomström-LundqvistA Rudin
Aug 1, 1994·British Heart Journal·L Storstein
Jan 1, 1985·Postgraduate Medical Journal·M HussainD B Morgan
Aug 1, 1992·American Journal of Public Health·B E KleinR Klein
Sep 23, 2003·QJM : Monthly Journal of the Association of Physicians·S G Chrysant
Jan 22, 2014·Expert Opinion on Pharmacotherapy·Juan TamargoLuis M Ruilope
Jan 26, 2010·Expert Opinion on Drug Safety·Pantelis A SarafidisAnastasios N Lasaridis

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.